Integrated Diagnostics

company

About

Integrated Diagnostics develops tools to help physicians diagnose complex diseases with a non-invasive blood test.

  • 11 - 50

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$17M
Integrated Diagnostics has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Apr 29, 2014 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 29, 2014 Debt Financing $17M 1 Detail
Jul 14, 2005 Series A 2 Detail

Investors

Number of Lead Investors
Number of Investors
3
Integrated Diagnostics is funded by 3 investors. Life Sciences Alternative Funding and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Life Sciences Alternative Funding Debt Financing
ARCH Venture Partners Series A
Versant Ventures Series A